Sylvest Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Buy
9,420
+1,335
+17% +$81.9K 0.21% 56
2026
Q1
$528K Buy
8,085
+2,132
+36% +$156K 0.28% 49
2025
Q4
$479K Buy
5,953
+321
+6% +$25.8K 0.26% 53
2025
Q3
$462K Buy
5,632
+809
+17% +$70.1K 0.25% 59
2025
Q2
$440K Buy
4,823
+612
+15% +$54.7K 0.25% 61
2025
Q1
$385K Buy
4,211
+825
+24% +$72K 0.24% 64
2024
Q4
$288K Buy
+3,386
New +$297K 0.18% 67

Other funds holding DOX

Sylvest Advisors's DOX Position: Q2 2026 in Review

Sylvest Advisors increased its Amdocs (DOX) stake by 17% in Q2 2026, buying an estimated $81.9K and bringing the position to 9,420 shares worth $476K. The position accounts for 0.21% of the portfolio, ranked #56.

Sylvest Advisors first reported a position in DOX in Q4 2024 and has held it in 7 quarters since. The position peaked at $528K in Q1 2026. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Sylvest Advisors held 9,420 shares of Amdocs worth $476K as of Q2 2026.
  • Sylvest Advisors bought 1,335 Amdocs shares in Q2 2026, an estimated $81.9K.
  • Amdocs made up 0.21% of Sylvest Advisors's portfolio in Q2 2026, its #56 holding.
  • Sylvest Advisors first reported a position in Amdocs in Q4 2024 and has held it in 7 quarters since.
  • Sylvest Advisors's Amdocs position peaked at $528K in Q1 2026.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Sylvest Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.